ciclesonide (Omnaris, Alvesco, Zetonna)
Jump to navigation
Jump to search
Indications
- seasonal & perennial allergic rhinitis & atopy in adults & children 12 years of age & up (Omnaris)
- asthma & COPD (Alvesco)[6]
Dosage
- Nasal spray, 2 sprays QD
- Inhalation aerosol (MDI): [4]
80 ug/puff & 160 ug/puff
Mechanism of action
Notes
Manufacturer: Alta Pharma, Nycomed
More general terms
References
- ↑ Prescriber's Letter 14(2): 2007 New drugs approved by the FDA in 2006 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=2302213&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ Prescriber's Letter 14(6): 2007 New Nasal Steroids: Veramyst and Omnaris Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230610&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ Prescriber's Letter 15(6): 2008 Nasal Sprays for Allergic Rhinitis Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=240609&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 4.0 4.1 Prescriber's Letter 15(9): 2008 New Formulation: Alvesco (Ciclesonide Inhalation Aerosol) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=240908&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 5.0 5.1 Prescriber's Letter 19(9): 2012 Nasal Sprays for Allergic Rhinitis Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=280910&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 6.0 6.1 Deprecated Reference